Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans

Condition:   Crimean-Congo Hemorrhagic Fever Interventions:   Biological: KIRIM-KONGO-VAX;   Other: Placebo Sponsors:   Tubitak;   MonitorCRO Active, not recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials